Acer Therapeutics Inc (ACER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -29,418 | -24,262 | -19,010 | -7,969 | -21,281 |
| Depreciation Amortization | 58 | 41 | 27 | 10 | 28 |
| Accounts payable and accrued liabilities | -473 | -1,004 | 505 | -973 | 938 |
| Other Working Capital | -2,818 | -3,303 | -597 | -2,464 | 3,347 |
| Other Operating Activity | 3,143 | 3,013 | 935 | 1,645 | 380 |
| Operating Cash Flow | $-29,507 | $-25,516 | $-18,140 | $-9,751 | $-16,588 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -179 | -126 | -135 | -89 | -96 |
| Investing Cash Flow | $-179 | $-126 | $-135 | $-89 | $-96 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 92 | 92 | 92 | N/A | 42,710 |
| Financing Cash Flow | $92 | $92 | $92 | $N/A | $42,710 |
| Beginning Cash Position | 41,671 | 41,671 | 41,671 | 41,671 | 15,644 |
| End Cash Position | 12,078 | 16,122 | 23,488 | 31,831 | 41,671 |
| Net Cash Flow | $-29,594 | $-25,549 | $-18,183 | $-9,840 | $26,027 |
| Free Cash Flow | |||||
| Operating Cash Flow | -29,507 | -25,516 | -18,140 | -9,751 | -16,588 |
| Capital Expenditure | -179 | -126 | -135 | -89 | -96 |
| Free Cash Flow | -29,686 | -25,642 | -18,275 | -9,840 | -16,683 |